Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Do Not Throw Out the Resveratrol With the Bath Water

Do Not Throw Out the Resveratrol With the Bath Water Letters Minneapolis (Lopez, Folsom); Ciccarone Center for the Prevention of Heart Medication use was verified by reviewing medications Disease, Johns Hopkins School of Medicine, Baltimore, Maryland (Blaha); that participants brought to the visit. We analyzed the preva- Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, lence of indications for statin therapy according to ACC/AHA Houston, Texas (Virani); Department of Epidemiology, Johns Hopkins guidelines and ATP III guidelines (which were the most rel- Bloomberg School of Public Health, Baltimore, Maryland (Coresh); Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, evant guidelines at the time of ARIC visit 5) and the use of Houston, Texas (Ballantyne); Houston Methodist DeBakey Heart and Vascular statins and other medications to lower lipid levels. Center, Houston, Texas (Ballantyne). Corresponding Author: Michael D. Miedema, MD, MPH, Minneapolis Heart Results | A considerable portion of the ARIC cohort used Institute, Minneapolis Heart Institute Foundation, 800 E 28th St, Minneapolis, medication to lower lipid levels at visit 5, but uncontrolled MN 55414 (mdm307@mail.harvard.edu). hyperlipidemia was still common according to the ATP III Published Online: November 17, 2014. doi:10.1001/jamainternmed.2014.6288. guidelines then in place (Table 1). Individuals with a high Author Contributions: Dr Miedema and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Do Not Throw Out the Resveratrol With the Bath Water

Loading next page...
 
/lp/american-medical-association/do-not-throw-out-the-resveratrol-with-the-bath-water-Qu55llp0F6
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2014.7000
pmid
25560944
Publisher site
See Article on Publisher Site

Abstract

Letters Minneapolis (Lopez, Folsom); Ciccarone Center for the Prevention of Heart Medication use was verified by reviewing medications Disease, Johns Hopkins School of Medicine, Baltimore, Maryland (Blaha); that participants brought to the visit. We analyzed the preva- Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, lence of indications for statin therapy according to ACC/AHA Houston, Texas (Virani); Department of Epidemiology, Johns Hopkins guidelines and ATP III guidelines (which were the most rel- Bloomberg School of Public Health, Baltimore, Maryland (Coresh); Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, evant guidelines at the time of ARIC visit 5) and the use of Houston, Texas (Ballantyne); Houston Methodist DeBakey Heart and Vascular statins and other medications to lower lipid levels. Center, Houston, Texas (Ballantyne). Corresponding Author: Michael D. Miedema, MD, MPH, Minneapolis Heart Results | A considerable portion of the ARIC cohort used Institute, Minneapolis Heart Institute Foundation, 800 E 28th St, Minneapolis, medication to lower lipid levels at visit 5, but uncontrolled MN 55414 (mdm307@mail.harvard.edu). hyperlipidemia was still common according to the ATP III Published Online: November 17, 2014. doi:10.1001/jamainternmed.2014.6288. guidelines then in place (Table 1). Individuals with a high Author Contributions: Dr Miedema and

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 1, 2015

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month